Infectious Disease Specialists, primary care physicians
Cardiovascular Disease, HIV-1 Infection, Management Of HIV-1 Infection, Patient Adherence, Renal Dysfunction
With the development of more effective and better tolerated therapies for HIV-1 infection, patients are living longer with this disease. There is high and comparable efficacy among many of the treatment regimens for HIV-1, but they vary in regard to pill burden, dosing frequency, potential long- and short-term side effects, barriers to resistance, and drug interactions. Treatments for patients with HIV-1 must be individualized and choice is based on convenience, side-effect profile, known or suspected resistance, and interactions with concomitant medications, along with the presence or absence of comorbidities such as cardiovascular disease, renal dysfunction, psychiatric illness, and substance-use history.
New Insights into Managing HIV-1 will review the recent updates to the guidelines for the management of HIV-1 infection and present new data on the efficacy/tolerability profiles of various treatment regimens to enhance patient care and optimize overall outcomes.
DISCLOSURE POLICY STATEMENT
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
The faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Raphael J. Landovitz, MD, MSc: Nothing to disclose
Paul Sax, MD: Consultant/Advisory board: AbbVie, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen, Merck; Research: Bristol-Myers Squibb, Gilead, GlaxoSmithKline
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Carole Drexel, PhD, CCMEP; Blair St. Amand; Jay Katz, CCMEP; Tim Kuberski, MD: Nothing to disclose
Joel Gallant, MD: Research: AbbVie, Bristol-Myers Squibb, Gilead, Merck, Sangamo BioSciences, ViiV Healthcare; Advisor: Bristol-Myers Squibb, Gilead, Janssen, Merck; Data Safety Monitoring Board: Takara Bio Inc.
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
The Potomac Center for Medical Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, the post-test, or evaluation, please email email@example.com.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.0 AMA PRA category 1 credits™. Statement of credit will be available to print from your user history page.
|Supported Browsers: |
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 7.0+ for Mac OSX 10.7 and above
For video playback, install the latest version of Flash or Quicktime.
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above